Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Torres, Ivan J
Kozicky, Jan
Popuri, Swetha
Bond, David J
Honer, William G
Lam, Raymond W
and
Yatham, Lakshmi N
2014.
12‐month longitudinal cognitive functioning in patients recently diagnosed with bipolar disorder.
Bipolar Disorders,
Vol. 16,
Issue. 2,
p.
159.
Hutton, P.
and
Taylor, P. J.
2014.
Cognitive behavioural therapy for psychosis prevention: a systematic review and meta-analysis.
Psychological Medicine,
Vol. 44,
Issue. 3,
p.
449.
Llovera, Freund
Ramos, P.R. García
and
Ballesteros, A. Ayala
2015.
Psicosis.
Medicine - Programa de Formación Médica Continuada Acreditado,
Vol. 11,
Issue. 85,
p.
5086.
Bora, E.
2015.
Neurodevelopmental origin of cognitive impairment in schizophrenia.
Psychological Medicine,
Vol. 45,
Issue. 1,
p.
1.
Leucht, S.
Winter-van Rossum, I.
Heres, S.
Arango, C.
Fleischhacker, W. W.
Glenthoj, B.
Leboyer, M.
Leweke, F. M.
Lewis, S.
McGuire, P.
Meyer-Lindenberg, A.
Rujescu, D.
Kapur, S.
Kahn, R. S.
and
Sommer, I. E.
2015.
The Optimization of Treatment and Management of Schizophrenia in Europe (OPTiMiSE) Trial: Rationale for its Methodology and a Review of the Effectiveness of Switching Antipsychotics.
Schizophrenia Bulletin,
Vol. 41,
Issue. 3,
p.
549.
Strejilevich, Sergio A.
Samamé, Cecilia
and
Martino, Diego J.
2015.
The trajectory of neuropsychological dysfunctions in bipolar disorders: A critical examination of a hypothesis.
Journal of Affective Disorders,
Vol. 175,
Issue. ,
p.
396.
Wu, Bo-Jian
Liao, Hsun-Yi
Chen, Hsing-Kang
and
Lan, Tsuo-Hung
2016.
Psychopathology, psychopharmacological properties, decision-making capacity to consent to clinical research and the willingness to participate among long-term hospitalized patients with schizophrenia.
Psychiatry Research,
Vol. 237,
Issue. ,
p.
323.
Leucht, Stefan
Rossum, Inge Winter-van
Heres, Stephan
Arango, Celso
Fleischhacker, W. Wolfgang
Glenthøj, Birte
Leboyer, Marion
Leweke, F. Markus
Lewis, Shôn
McGuire, Phillip
Meyer-Lindenberg, Andreas
Rujescu, Dan
Kapur, Shitij
Kahn, René S.
and
Sommer, Iris E.
2016.
The Optimization of Treatment and Management of Schizophrenia in Europe (OPTiMiSE) Trial: Rationale for Its Methodology and a Review of the Effectiveness of Switching Antipsychotics.
Focus,
Vol. 14,
Issue. 3,
p.
378.
van den Berg, David P.G.
van der Vleugel, Berber M.
de Bont, Paul A.J.M.
Staring, Anton B.P.
Kraan, Tamar
Ising, Helga
de Roos, Carlijn
de Jongh, Ad
van Minnen, Agnes
and
van der Gaag, Mark
2016.
Predicting trauma-focused treatment outcome in psychosis.
Schizophrenia Research,
Vol. 176,
Issue. 2-3,
p.
239.
Bora, Emre
Hıdıroğlu, Ceren
Özerdem, Ayşegül
Kaçar, Ömer Faruk
Sarısoy, Gökhan
Civil Arslan, Filiz
Aydemir, Ömer
Cubukcuoglu Tas, Zeynep
Vahip, Simavi
Atalay, Adnan
Atasoy, Nuray
Ateşci, Figen
and
Tümkaya, Selim
2016.
Executive dysfunction and cognitive subgroups in a large sample of euthymic patients with bipolar disorder.
European Neuropsychopharmacology,
Vol. 26,
Issue. 8,
p.
1338.
Moritz, Steffen
Bentall, Richard P.
Kolbeck, Katharina
and
Roesch-Ely, Daniela
2018.
Monocausal attribution and its relationship with reasoning biases in schizophrenia.
Schizophrenia Research,
Vol. 193,
Issue. ,
p.
77.
Omachi, Yoshie
and
Sumiyoshi, Tomiki
2018.
Dose Reduction/Discontinuation of Antipsychotic Drugs in Psychosis; Effect on Cognition and Functional Outcomes.
Frontiers in Psychiatry,
Vol. 9,
Issue. ,
Studerus, Erich
Corbisiero, Salvatore
Mazzariello, Nadine
Ittig, Sarah
Leanza, Letizia
Egloff, Laura
Beck, Katharina
Heitz, Ulrike
Andreou, Christina
Stieglitz, Rolf-Dieter
and
Riecher-Rössler, Anita
2018.
Can neuropsychological testing facilitate differential diagnosis between at-risk mental state (ARMS) for psychosis and adult attention-deficit/hyperactivity disorder (ADHD)?.
European Psychiatry,
Vol. 52,
Issue. ,
p.
38.
Ballesteros, Alejandro
Sánchez-Torres, Ana M.
López-Ilundain, Jose M.
Cabrera, Bibiana
Lobo, Antonio
González-Pinto, Ana M.
Díaz-Caneja, Covadonga
Corripio, Iluminada
Vieta, Eduard
de la Serna, Elena
Bobes, Julio
Usall, Judith
Contreras, Fernando
Lorente-Omeñaca, Ruth
Mezquida, Gisela
Bernardo, Miguel
and
Cuesta, Manuel J.
2018.
Is cognitive impairment associated with antipsychotic dose and anticholinergic equivalent loads in first-episode psychosis?.
Psychological Medicine,
Vol. 48,
Issue. 13,
p.
2247.
Kaar, S. J.
Gobjila, C.
Butler, E.
Henderson, C.
and
Howes, O. D.
2019.
Making decisions about antipsychotics: a qualitative study of patient experience and the development of a decision aid.
BMC Psychiatry,
Vol. 19,
Issue. 1,
Thanontip, Kamonwan
Chetsawang, Banthit
and
Chumchua, Vasunun
2019.
Novel Protein-Protein Interaction Network of Antipsychotic Drugs and Cognitive Function.
p.
1.
Weller, Amber
Gleeson, John
Alvarez‐Jimenez, Mario
McGorry, Patrick
Nelson, Barnaby
Allott, Kelly
Bendall, Sarah
Bartholomeusz, Cali
Koval, Peter
Harrigan, Susy
O'Donoghue, Brian
Fornito, Alex
Pantelis, Christos
Paul Amminger, G.
Ratheesh, Aswin
Polari, Andrea
Wood, Stephen J.
van der El, Kristi
Ellinghaus, Carli
Gates, Jesse
O'Connell, Jessica
Mueller, Marianne
Wunderink, Lex
and
Killackey, Eóin
2019.
Can antipsychotic dose reduction lead to better functional recovery in first‐episode psychosis? A randomized controlled‐trial of antipsychotic dose reduction. The reduce trial: Study protocol.
Early Intervention in Psychiatry,
Vol. 13,
Issue. 6,
p.
1345.
Morrison, Anthony P.
2019.
Should people with psychosis be supported in choosing cognitive therapy as an alternative to antipsychotic medication: A commentary on current evidence.
Schizophrenia Research,
Vol. 203,
Issue. ,
p.
94.
Begemann, Marieke J. H.
Thompson, Ilse A.
Veling, Wim
Gangadin, Shiral S.
Geraets, Chris N. W.
van ‘t Hag, Erna
Müller-Kuperus, Sanne J.
Oomen, Priscilla P.
Voppel, Alban E.
van der Gaag, Mark
Kikkert, Martijn J.
Van Os, Jim
Smit, H. Filip E.
Knegtering, Rikus H.
Wiersma, Sybren
Stouten, Luyken H.
Gijsman, Harm J.
Wunderink, Lex
Staring, Anton B. P.
Veerman, Selene R. T.
Mahabir, Amrita G. S.
Kurkamp, Jörg
Pijnenborg, Gerdina H. M.
Veen, Natalie D.
Marcelis, Machteld
Grootens, Koen P.
Faber, Gunnar
van Beveren, Nico J.
Been, Agaath
van den Brink, Truus
Bak, Maarten
van Amelsvoort, Therese A. M. J.
Ruissen, Andrea
Blanke, Christine
Groen, Karin
de Haan, Lieuwe
and
Sommer, Iris E. C.
2020.
To continue or not to continue? Antipsychotic medication maintenance versus dose-reduction/discontinuation in first episode psychosis: HAMLETT, a pragmatic multicenter single-blind randomized controlled trial.
Trials,
Vol. 21,
Issue. 1,
Barnes, Thomas RE
Drake, Richard
Paton, Carol
Cooper, Stephen J
Deakin, Bill
Ferrier, I Nicol
Gregory, Catherine J
Haddad, Peter M
Howes, Oliver D
Jones, Ian
Joyce, Eileen M
Lewis, Shôn
Lingford-Hughes, Anne
MacCabe, James H
Owens, David Cunningham
Patel, Maxine X
Sinclair, Julia MA
Stone, James M
Talbot, Peter S
Upthegrove, Rachel
Wieck, Angelika
and
Yung, Alison R
2020.
Evidence-based guidelines for the pharmacological treatment of schizophrenia: Updated recommendations from the British Association for Psychopharmacology.
Journal of Psychopharmacology,
Vol. 34,
Issue. 1,
p.
3.
Comments
No Comments have been published for this article.